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CASE REPORTS
Salivary gland tumour of the lip: report of two cases and literature
review
*M E A SU Q U O , * 0 0  O TEI, *R  E K PO , * 1 A B A N G , *U A D A M S, **EE BA SSEY , **G  E B U G H E
Abstract
Background: Salivary gland tumours (SGT'S) are uncommon. The minor glands are dispersed throughout 
the upper aerodigestive submucosa including the lip.
Objective: To present two case reports o f  salivary gland tumour o f  the upper lip and highlight its diagnostic 
and therapeutic challenges.
Case reports: A  50 year old female farmer presented with a two year history o f  sw elling o f  the upper lip and 
the histology revealed a pleomorphic adenoma o f  the minor salivary gland. She was offered a wide excision  
which resulted in a huge upper lip defect managed by a two staged lip switch A BBE flap. The second patient, a 
40 year old female teacher presented with a lOyear history o f  a left sided upper lip swelling. H istology  
revealed pleomorphic adenoma. She was offered an excision with no evidence o f  recurrence after 26 months 
o f  follow  up.
Conclusion: Salivary gland tumours should be considered as a differential diagnosis o f  tumours o f  the lip. 
Early presentation is advocated as late presentation with advanced tumour presents diagnostic and 
therapeutic challenges.
Introduction
Salivary gland tumours (SGT'S) are uncommon; they 
represent 2.4% of head and neck neoplasm and include 
tumours affecting both major and minor salivary 
glands.1'2 The glands are divided into major and minor 
salivary gland categories. The major salivary glands 
are the parotid, submandibular and sublingual glands. 
The minor glands are dispersed throughout the upper 
aerodigestive submucosa (palate, tongue, lip, pharynx, 
nasopharynx, larynx, parapharyngeal space) and
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account for 22% of tumours.2 The lip has three major 
anatomical parts; skin, muscle and mucous membrane 
with numerous salivary glands in the submucosa. 
Pleomorphic adenomas (benign mixed tumours) are 
the most common benign SGT and comprise 85% of all 
salivary gland neoplasms.2 However, the incidence of 
SGT'S is claimed to be influenced by geographic and 
racial factors.3 African reports suggest a pattern that 
significantly differs from that of western countries.4 
The ubiquitous deposits of the minor salivary glands 
complicate the diagnosis and management.2 We
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present two cases, one of which was an advanced 
tumour of the minor salivary gland of the upper lip, to 
highlight the diagnostic and therapeutic challenges.
Case Report 1: EES, 130615, a 50 year old female 
trader presented with a two year history of swelling of 
the upper lip. This lesion started as a small painless 
swelling that involved the inner part of the upper lip. It 
progressively increased in size, resulted in difficulty in 
moving the upper lip and affected her phonation. There 
was no history of trauma, itching, smoking or exposure 
to radiation. She applied topical local herbal 
medications, rinsed her mouth with local gin and 
consulted some medical facilities, to no avail. 
Presentation to the University of Calabar Teaching 
Hospital was prompted when the mass began to bleed 
on contact.
Examination revealed a middle age female, afebrile, 
not pale. There was a huge, irregular, firm, fungating 
multilobulated mass involving the upper lip measuring 
16cm across the widest diameter, (Figure la). It was 
attached to the skin and mucosa with multiple 
ulcerations. The lesion was not tender, neither pulsatile 
nor warmer than the surrounding. There was no 
regional lymphadenopathy. Chest and abdomen were 
normal.
Figure la: Salivary gland tumour; oral view.
showed a tumour composed of myoepithelial like cells 
in a myxoid background with chondroid looking cells. 
The tissue was lined by non keratinised epithelium. 
There was no atypia- pleomorphic adenoma, (Figure 
lb).
Figure lb: Pleomorphic adenoma; H & E x 40.
She had an excision and a two staged upper lip 
reconstruction with lip switch ABBE flap, (Figure Ic). 
Follow up has been for three months.
Figure 1c: Post excision and upper lip reconstruction.
Case Report 2: FOE 066932, a 40 year old female 
teacher presented with a 10 year history of a slow 
growing swelling that involved the upper lip. This was 
first noticed while brushing her teeth. There was no 
previous history of trauma or itching, she neither 
smoked nor was exposed to radiation and used 
traditional herbal medication to no avail.
Examination revealed a middle aged female, afebrile 
and not pale. There was a left sided upper lip mass, 
firm, non tender mobile mass that measured 4x3 cm, 
(Figure Ila). It was not attached to skin or mucosa and 
there was no regional lymphadenopathy. Chest and 
abdomen was normal. Work up revealed a PCV of 30%, 
WBC 3.6x109/l and a normal urinalysis.
Figure la: Salivary gland tumour; facial view.
Work up revealed a PCV of 30%, WBC 3.0xl07l. 
Urinalysis and chest X-ray were normal. Biopsy
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Figure Ha: Salivary gland tumour.
She was offered excision through an oral route with 
local infiltration using lignocaine. Histology revealed 
pleomorphic adenoma, (Figure lib). Follow up has 
been for 26 months with no evidence of recurrence.
Figure lib: Pleomorphic adenoma; H  & E x 40.
D iscussion
The rarity of SGT'S in addition to few reported cases on 
minor salivary tumour lessens its clinical awareness.1 
Generally the major salivary gland has the highest 
incidence of tumours with 85% being pleomorphic 
adenoma (parotid, 70%, submandibular 8%, minor, 
22%).2 However, Edda m Uganda3 reported a low 
proportion of tumour from parotid and high proportion 
of tumours of the submandibular and minor salivary 
glands (parotid, 30%, submandibular, 33.2% and 
32.8% from minor salivary glands). In Ethiopia minor 
SGT constituted 31.9% of SGT'S.4 Odukoya in Lagos, 
Nigeria reported a higher percentage of minor SGT'S, 
68.9% and major, 31.1%.5 African series have 
suggested a pattern of presentation that significantly 
differs from that of western countries.4 The 
presentation of these patients is aimed at increasing the 
awareness of this tumour that may present in grotesque 
picture with therapeutic challenges as depicted in Case 
1.
The highest incidence has been found in patients in 
the fifth to seventh decade with females commonly 
affected.1,3 Our patients were females in the fourth and 
fifth decades. Chalin2 reported the peak age of third to 
fourth decade and Odukoya5 in Nigeria reported a mean 
age of 31 years (11 to 75 years) with a slight male 
preponderance (8:7) on pleomorphic adenoma of 
minor and major salivary glands.
The ubiquitous depositions of minor salivary glands 
complicate diagnosis and management. The classic 
presentation of benign SGT'S is a painless slow 
growing mass but because of the multiple and varied 
site of the minor salivary gland the presentation may be 
less specific. Pleomorphic adenomas (benign mixed 
tumours) are the most common tumour of the salivary 
gland. When found in the minor salivary glands the 
hard palate is the site most frequently involved 
followed by the upper lip, the site involved in our 
patients. Tumours of the lip could arise from the skin, 
muscle and the mucosa. Clinical diagnosis may be 
possible with early presentation when the lesion is 
confined to the tissue of origin. Late presentation with 
grotesque picture as was in Case 1 made clinical 
diagnosis difficult as the skin and muscles were 
involved and diagnosis was made on histology.
Histologic diagnosis is required prior to definitive 
surgical treatment. Fine needle aspiration cytology 
(FNAC) may aid in the diagnosis with the aid of an 
experienced cytologist but histology is required for 
final pathologic diagnosis.2 Magnetic resonance 
imaging,(MRI) is the most sensitive for establishing 
the borders o f soft tissue tumour extension. 
Computerised tomography (CT) and MRI may not 
differentiate benign from malignant disease reliably.2 
The histologic diagnosis o f our patient was 
pleomorphic adenoma, (Figure lb, lib). It comprised 
myoepithelial-like cells in a myxoid background with 
chondroid looking cells and was lined by non 
keratinised epithelium. They are termed pleomorphic 
because of epithelial and connective tissue components 
which occur in varying degrees. Pleomorphic adenoma 
originates from the intercalated duct cells and 
myoepithelial cells. Oncocytic tumours originate from 
striated ducts cells, acini cell tumour from acinar cells, 
mucoepidermiod and squamous cell tumour from 
excretory duct cells.2 Odukoya in Lagos5 observed less 
chondroid cells in minor than major salivary glands and 
remarked that tumours with epithelial tissue 
predom inance w ere g enera lly  b igger than 
mesenchymal tissue predominance.
Pleomorphic adenomas from the minor salivary 
glands usually lack a capsule, consequently the 
avoidance of spillage at surgery is required to minimise 
recurrence. Benign neoplasm requires complete 
surgical excision and MOH’S micrographic surgery 
(MMS) is the gold standard. Our patient (Case 1) was 
offered wide excision which resulted in a huge upper 
lip defect managed by a two staged lip switch ABBE 
flap. Case 2 had excision and primary closure under 
local anaesthesia because the tumour was localised and
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posed no therapeutic challenge.
Tumours of the minor salivary glands should be 
considered in the diagnosis of patients with lip lesions. 
Early presentation would improve outcome and follow 
up is required as the risk of tumour recurrence is high.
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